Anti-venom Market, by Anti-venom Type (Polyvalent, Monovalent), by Product Type (Snake Anti-venom, Scorpion Anti-venom, Spider Anti-venom, Other Anti-venom product), by Distribution Channel (Hospitals, Private Clinics, Ambulatory Surgical Centers) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2026 – 2026

  • To Be Published : Dec 2018 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Anti-venom is a medication majorly used to treat snake bites and it can also be used to treat bites from scorpions, spiders or other reptiles. It is made by fractionating the blood of the donor (horse or sheep), which is hyper immunized with snake venom. These products are available in either lyophilized or liquid forms.  Anti-venom is the only effective therapy against snake bites and apart from lifesaving, they also save patients from cell and tissue necrosis, thus helping save vital organs. As per World Health Organization (WHO) fact sheet, 4.5 to 5.4 million people are bitten by snakes, every year, globally, out of which 1.8 to 2.7 million people develop clinical illnesses after snake bites and up to 81,000 to 1, 38,000 people die from such snake bites. Snake bite causes around 400,000 amputations and other permanent disabilities, annually.

South Asia and Africa are expected to drive growth of the anti-venom market, owing to higher incidence of snakebites

Growth of the anti-venom market is expected to be driven by South Asia and sub-Saharan African countries due to highest incidence of snake bites in these regions. As per WHO statistics, in India, 3.8 million people are bitten by snakes and 46,900 people die every year. In sub-Saharan Africa, around 7,000 to 20,000 people die annually from snake bites. Highest incidence is recorded in rural and peri-urban areas, where croppers and livestock workers live. However, growing urbanization is resulting in the loss of habitat for many snake species due to deforestation, thus drawing them towards area inhabited by humans, in turn, increasing the incidence of snakebites. The WHO, in June 2017, added snakebite to its priority list of neglected tropical disease, which would result in more focused effort to prevent death from snakebite, thus boosting growth of the anti-venom market. Increasing government funding for research and development and logistics in these countries is further drive growth of the global anti-venom market. Anti-venom product requires specialized infrastructure such as cold chain storage, which is not available adequately in highly prone regions such as Africa and Asia. This in turn, is hindering the supply of anti-venom products in these regions.

However, high costs associated with anti-venom products (due to high manufacturing cost) hinders growth of the anti-venom market. Lack of access to anti-venom products is also one of the major constraints for market growth. According to WHO, most of the sub-Saharan African region does not locally produce anti-venom, thus the populace in this region relies on traditional treatment to treat snakebites. Countries in this region often face chronic shortage of anti-venom production, thus, creating opportunities for market players to enter the anti-venom market. Presently, the available anti-venom product is not effective against snake bites from certain species such as hump-nosed vipers (India) and other species present in African counties. This in turn, is limiting market expansion.

Market Segmentation of the Global Anti-venom Market:

On the basis of anti-venom type:

  • Monovalent (Hyper immunizing venom obtained from single species)
  • Polyvalent (Hyper immunizing venom from two or more species)

On the basis of product type: 

  • Snake anti-venom
  • Scorpion anti-venom
  • Spider anti-venom
  • Other anti-venom products

On the basis of distribution channel:

  • Hospitals
  • Private clinics
  • Ambulatory surgical centers

Ongoing research in the anti-venom products market is increasing the scope for market growth. Venomab is a company focusing on production of anti-venom, by using humanized antibodies instead of traditional serum-based animal derived anti-venom. This in turn, would reduce cost and scale up the production, alongside would improve availability of the products.

The anti-venom market is dominated mostly by the producers from emerging economies such as India, Brazil, and Mexico. In 2014, Sanofi Pasteur announced that it would not produce its anti-venom product Fav-Afrique (mostly sold in African countries), which is one of the most effective polyvalent anti-venom products. This was due to tough competition from low cost manufacturers from emerging economies such as India, Brazil, and Mexico. Key players present in the anti-venom market include Haffkine Bio-Pharmaceutical Corporation Ltd., Bharat Serums and Vaccines Ltd, Vins Bioproducts Limited, CSL Behring, Vacsera, Rare Therapeutics, Instituto Bioclon C.V., and Incepta Vaccine Ltd.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.